biote Corp 10-Q for FY2021 Q2
biote Corp. (BTMD)
About this 10-Q
biote Corp filed this 10-Q on August 17, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net income
- $13.24M
| QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fourth of one Redeemable Warrant |
||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
Page |
||||||
PART 1 - FINANCIAL INFORMATION |
||||||
Item 1. |
||||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
Item 2. |
21 |
|||||
Item 3. |
24 |
|||||
Item 4. |
24 |
|||||
PART II - OTHER INFORMATION |
||||||
Item 1. |
25 |
|||||
Item 1A. |
25 |
|||||
Item 2. |
25 |
|||||
Item 3. |
25 |
|||||
Item 4. |
25 |
|||||
Item 5. |
25 |
|||||
Item 6. |
26 |
|||||
26 |
||||||
June 30, 2021 |
December 31, 2020 |
|||||||
| (Unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
— | |||||||
Total current assets |
||||||||
Prepaid insurance - non-current |
— |
|||||||
Deferred offering costs |
— | |||||||
Investments held in Trust Account |
||||||||
Total Assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Franchise tax payable |
— | |||||||
Sponsor note |
— | |||||||
Total current liabilities |
||||||||
Warrant liabilities |
— | |||||||
Deferred underwriting fee payable |
— | |||||||
Total Liabilities |
||||||||
Commitments (see Note 6) |
||||||||
Class A common stock, $ |
— | |||||||
Stockholders’ Equity: |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
— | |||||||
Class B common stock, $ (1) and (2) shares issued and outstanding at June 30, 2021 and December 31, 2020 |
||||||||
Additional paid-in capital |
— | |||||||
Retained earnings |
— | |||||||
Total Stockholders’ Equity |
||||||||
Total Liabilities and Stockholders’ Equity |
$ | $ | ||||||
| (1) | Excludes |
| (2) | Includes an aggregate of |
Three Months Ended June 30, 2021 |
Six Months Ended June 30, 2021 |
|||||||
| Operating and formation costs |
$ | $ | ||||||
| Transaction costs allocated to warrant liabilities |
||||||||
| Franchise tax expense |
||||||||
| |
|
|
|
|||||
| Loss from operations |
( |
) | ( |
) | ||||
| Unrealized gain on investments held in Trust Account |
( |
) | ||||||
| Excess of private placement warrants fair value over purchase price |
— | ( |
) | |||||
| Change in fair value of warrant liabilities |
||||||||
| |
|
|
|
|||||
| Net income |
$ | $ | ||||||
| |
|
|
|
|||||
| Basic and diluted weighted average shares outstanding, Redeemable Class A Common Stock |
||||||||
| |
|
|
|
|||||
| Basic and diluted net loss per share, Redeemable Class A Common Stock |
$ | ( |
) | $ | ||||
| |
|
|
|
|||||
| Basic and diluted weighted average shares outstanding, Non-Redeemable Class A and Class B Common Stock |
||||||||
| |
|
|
|
|||||
| Basic and diluted net income per share, Non-Redeemable Class A and Class B Common Stock |
$ | $ | ||||||
| |
|
|
|
|||||
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-in Capital |
(Accumulated Deficit) Retained Earnings |
Total Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balances, December 31, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Sale of |
— | — | — | |||||||||||||||||||||||||
| Forfeiture of Class B common stock |
( |
) | ( |
) | — | — | ||||||||||||||||||||||
| Class A common stock subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balances, March 31, 2021 |
( |
) | ||||||||||||||||||||||||||
| Class A common stock subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | ( |
) |
( |
) | ||||||||||||||||
| Transaction costs allocated to warrant liabilities related to Initial Public Offering |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balances, June 30, 2021 |
$ |
$ |
$ |
— | $ |
$ |
||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Cash Flows from Operating Activities: |
||||
| Net income |
$ | |||
| Adjustments to reconcile net income to net cash used in operations: |
||||
| Transaction costs allocated to warrant liabilities |
||||
| Unrealized gain on investments held in Trust Account |
( |
) | ||
| Excess of private placement warrants fair value over purchase price |
||||
| Change in fair value of warrant liabilities |
( |
) | ||
| Changes in operating assets and liabilities: |
||||
| Prepaid expenses |
( |
) | ||
| Franchise tax payable |
||||
| |
|
|||
| Net cash used in operating activities |
( |
) | ||
| |
|
|||
| Cash Flows from Investing Activities: |
||||
| Cash deposited into Trust Account |
( |
) | ||
| |
|
|||
| Net cash used in investing activities |
( |
) | ||
| |
|
|||
| Cash Flows from Financing Activities: |
||||
| Proceeds from initial public offering, net of underwriter’s discount paid |
||||
| Proceeds from Sponsor note |
||||
| Repayment of Sponsor note |
( |
) | ||
| Proceeds from sale of private placement warrants |
||||
| Payment of offering costs |
( |
) | ||
| |
|
|||
| Net cash provided by financing activities |
||||
| |
|
|||
| Increase in cash |
||||
| Cash at beginning of period |
||||
| |
|
|||
| Cash at June 30, 2021 |
$ |
|||
| |
|
|||
| Supplemental disclosure of noncash investing and financing activities: |
||||
| |
|
|||
| Deferred underwriting fee payable |
$ | |||
| |
|
|||
| Initial classification of warrant liabilities |
$ | |||
| |
|
|||
| Class A common stock subject to possible redemption |
$ | |||
| |
|
|||
| Reclassification of deferred offering costs to equity upon completion of the initial public offering |
$ | |||
| |
|
|||
Three Months Ended June 30, 2021 |
Six Months Ended June 30, 2021 |
|||||||
(Unaudited) |
(Unaudited) |
|||||||
Redeemable Class A Common Stock |
||||||||
Numerator: Earnings allocable to Redeemable Class A Common Stock |
||||||||
Unrealized (loss) gain on investments held in Trust Account |
$ | ( |
) | $ | ||||
Franchise tax expense |
( |
) | ||||||
Net (loss) earnings |
$ | ( |
) | $ | — | |||
Denominator: Weighted average Redeemable Class A Common Stock |
||||||||
Basic and diluted weighted average shares outstanding, Redeemable Class A Common Stock |
||||||||
Basic and diluted net earnings per share, Redeemable Class A Common Stock |
$ | $ | ||||||
Non-Redeemable Class A and Class B Common Stock |
||||||||
Numerator: Net income minus net earnings |
||||||||
Net income |
$ | $ | ||||||
Net earnings |
— | |||||||
Non-redeemable net income |
$ | $ | ||||||
Denominator: Weighted average Non-Redeemable Class A and Class B Common Stock |
||||||||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class A and Class B Common Stock |
||||||||
Basic and diluted net income per share, Non-Redeemable Class A and Class B Common Stock |
$ | $ | ||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon not less than “30-day redemption period”) to each warrant holder; and |
| • | if, and only if, the reported last sale price of the Class A common stock equals or exceeds $ |
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
June 30, 2021 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | — | $ | — | ||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | — | $ | — | ||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | — | $ | — | $ | ||||||||||
December 31, 2020 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | $ | ||||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | $ | $ | ||||||||||||
As of March 4 ,2021 |
||||
Stock Price on Valuation Date |
$ | |||
Strike price (Exercise Price Share) |
$ | |||
Probability of completing a Business Combination |
% | |||
Term (in years) |
||||
Volatility |
| |||
Risk-free rate |
% | |||
Fair value of warrants |
$ | |||
As of March 4 ,2021 |
As of June 30, 2021 |
|||||||
Stock price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Probability of completing a Business Combination |
% | % | ||||||
Dividend yield |
% | % | ||||||
Term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Fair value of warrants |
$ | $ | ||||||
Private Placement Warrants |
Public Warrants |
Warrant Liabilities |
||||||||||
Fair value as of December 31, 2020 |
$ | — | $ | — | $ | — | ||||||
Initial measurement as of March 4, 2021 |
||||||||||||
Additional warrants issued in over-allotment |
||||||||||||
Change in valuation inputs or other assumptions |
( |
) | ( |
) | ( |
) | ||||||
Fair value as of June 30, 2021 |
$ | $ | $ | |||||||||
| * | Filed herewith. |
| ** | Furnished. |
Haymaker Acquisition Corp. III | ||||||
| Date: August 17, 2021 | By: | /s/ Steven J. Heyer | ||||
| Name: Steven J. Heyer | ||||||
| Title: Chief Executive Officer | ||||||
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven J. Heyer, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Haymaker Acquisition Corp. III;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 17, 2021
| By: | /s/ Steven J. Heyer | |
| Steven J. Heyer | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |
27
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Christopher Bradley, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Haymaker Acquisition Corp. III;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 17, 2021
| By: | /s/ Christopher Bradley | |
| Christopher Bradley | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) |
28
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Haymaker Acquisition Corp. III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Steven J. Heyer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.
Date: August 17, 2021
| By: | /s/ Steven J. Heyer | |
| Steven J. Heyer | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |
29
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Haymaker Acquisition Corp. III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Christopher Bradley, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.
Date: August 17, 2021
| By: | /s/ Christopher Bradley | |
| Christopher Bradley | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) |
30